| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 1.316 | 0 | 9.606 | 0 | 0 | 0 | 0 | - | - |
| Total Income - EUR | - | 1.316 | 0 | 9.606 | 0 | 0 | 0 | 0 | - | - |
| Total Expenses - EUR | - | 978 | 0 | 84 | 0 | 0 | 0 | 263 | - | - |
| Gross Profit/Loss - EUR | - | 338 | 0 | 9.522 | 0 | 0 | 0 | -263 | - | - |
| Net Profit/Loss - EUR | - | 299 | 0 | 9.426 | 0 | 0 | 0 | -263 | - | - |
| Employees | - | 0 | 0 | 1 | 0 | 0 | 0 | 0 | - | - |
Check the financial reports for the company - Oxgen Profir Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 244 | 240 | 235 | 231 | 226 | 221 | 0 | - | - |
| Current Assets | - | 139 | 137 | 9.740 | 9.551 | 9.370 | 9.162 | 8.945 | - | - |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - |
| Receivables | - | 45 | 44 | 43 | 42 | 41 | 40 | 0 | - | - |
| Cash | - | 95 | 93 | 9.697 | 9.509 | 9.329 | 9.122 | 8.945 | - | - |
| Shareholders Funds | - | 344 | 338 | 9.758 | 9.569 | 9.387 | 9.179 | 8.945 | - | - |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | - | - |
| Debts | - | 39 | 39 | 218 | 213 | 209 | 205 | 0 | - | - |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4120 - 4120" | |||||||||
| CAEN Financial Year |
4120
|
|||||||||
Comments - Oxgen Profir Srl